Effectiveness and safety of secukinumab for psoriasis in real-world practice: analysis of subgroups stratified by prior biologic failure or reimbursement
Journal
Therapeutic advances in chronic disease
Journal Volume
10
Date Issued
2019
Author(s)
Abstract
Little is known about the treatment outcomes of secukinumab in clinical practice, which differ from those in clinical trials. The effectiveness of biologics may differ in psoriasis patients with previous biologics exposure. The objective of this study was to investigate the real-world effectiveness and safety of secukinumab therapy and analyze subgroups stratified by reimbursement or prior biologic failure.
Subjects
biologic failure; real-world; reimbursement; secukinumab; tumor necrosis factor-α inhibitors; ustekinumab
Publisher
SAGE PUBLICATIONS LTD
Type
journal article